More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Forbes, International Business Times, The Cannabis Reporter, and More Feature Medical Marijuana, Inc. This Week

Forbes, International Business Times, The Cannabis Reporter, and More Feature Medical Marijuana, Inc. This Week

by adminAdrianRamirez | Feb 4, 2019 | Dixie Botanicals, HempMeds, Media Coverage, Real Scientific Hemp Oil

CBD events, Valentine’s Day gift guides, CBD for Pets, and hemp legalization lead Medical Marijuana, Inc.’s top stories in the news this week. Here are the biggest headlines from the Medical Marijuana, Inc. family of companies from this past week, featuring the latest...
NFL Veteran Bryan Barker Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

NFL Veteran Bryan Barker Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

by adminAdrianRamirez | Jan 30, 2019 | Kannaway, Press Releases

SAN DIEGO, Jan. 30, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that NFL veteran Bryan Barker has become a spokesperson for its subsidiary Kannaway® to help spread awareness on...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Andrew Orona as National Sales Manager

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Andrew Orona as National Sales Manager

by adminAdrianRamirez | Jan 29, 2019 | Press Releases

SAN DIEGO, Jan. 29, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health has hired Andrew Orona as the National Sales Manager. Phyto Animal Health...
Medical Marijuana, Inc. Announces Re-Convened Virtual Annual Meeting to be Held on January 31, 2019

Medical Marijuana, Inc. Announces Re-Convened Virtual Annual Meeting to be Held on January 31, 2019

by adminAdrianRamirez | Jan 25, 2019 | Press Releases

SAN DIEGO, Jan. 25, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, is scheduled to hold its Re-convened Annual Meeting of Shareholders on Thursday, January 31, 2019 at 10:00 a.m. PT on the...
Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Former NBA All-Star James Donaldson

Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Former NBA All-Star James Donaldson

by adminAdrianRamirez | Jan 24, 2019 | Kannaway, Press Releases

SAN DIEGO, Jan. 24, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former NBA All-Star James Donaldson has become a spokesperson for its subsidiary Kannaway® to help spread...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.